ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Trading Down 2.7%

ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) traded down 2.7% during mid-day trading on Thursday . The company traded as low as $18.50 and last traded at $18.59. 3,780 shares changed hands during mid-day trading, a decline of 81% from the average session volume of 19,729 shares. The stock had previously closed at $19.11.

ProShares UltraShort Nasdaq Biotechnology Trading Down 3.2 %

The business has a fifty day moving average of $18.53 and a 200 day moving average of $19.89.

ProShares UltraShort Nasdaq Biotechnology Dividend Announcement

The business also recently disclosed a dividend, which was paid on Wednesday, March 27th. Stockholders of record on Thursday, March 21st were given a dividend of $0.1586 per share. The ex-dividend date was Wednesday, March 20th.

Institutional Investors Weigh In On ProShares UltraShort Nasdaq Biotechnology

A hedge fund recently bought a new stake in ProShares UltraShort Nasdaq Biotechnology stock. IMC Chicago LLC purchased a new stake in ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 15,001 shares of the company’s stock, valued at approximately $271,000. IMC Chicago LLC owned about 3.19% of ProShares UltraShort Nasdaq Biotechnology at the end of the most recent reporting period.

ProShares UltraShort Nasdaq Biotechnology Company Profile

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.